Boron-Doped Carbon Quantum Dots as a Novel Fluorescent Nanosensor for Imeglimin Determination: Green Synthesis, Analytical Validation, and Plasma Application
Analytical Methods · 2026
DOI: 10.1039/d6ay02030e ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Methods, 2026. Verfasst von Hany A. Batakoushy und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Imeglimin (IMN) is a novel oral antidiabetic drug for the management of type 2 diabetes mellitus. It is designed to enhance glycemic control by addressing mitochondrial bioenergetics. Ongoing monitoring of...
Zitieren
APA
Batakoushy, H. A., Salman, B., Al-Harrasi, A., Hara, M., Saraya, R. E., & Ibrahim, A. E. (2026). Boron-Doped Carbon Quantum Dots as a Novel Fluorescent Nanosensor for Imeglimin Determination: Green Synthesis, Analytical Validation, and Plasma Application. Analytical Methods. https://doi.org/10.1039/d6ay02030e
Vancouver
Batakoushy HA, Salman B, Al-Harrasi A, Hara M, Saraya RE, Ibrahim AE. Boron-Doped Carbon Quantum Dots as a Novel Fluorescent Nanosensor for Imeglimin Determination: Green Synthesis, Analytical Validation, and Plasma Application. Analytical Methods. 2026. doi:10.1039/d6ay02030e
BibTeX
@article{Batakoushy2026,
author = {Batakoushy, Hany A. and Salman, Baher and Al-Harrasi, Ahmed and Hara, Mohammed and Saraya, Roshdy E. and Ibrahim, Adel Ehab},
title = {Boron-Doped Carbon Quantum Dots as a Novel Fluorescent Nanosensor for Imeglimin Determination: Green Synthesis, Analytical Validation, and Plasma Application},
journal = {Analytical Methods},
year = {2026},
doi = {10.1039/d6ay02030e}
}
EUVIMED